UCB: Financiële kalender en winstcijfers | UCB | BE0003739530 | MarketScreener (2024)

UCB

Toevoegen aan een lijst

Om deze functie te gebruiken moet u een klant of lid zijn.

InloggenRegistreren

Aandelen

UCB

BE0003739530

Beurs gesloten - Euronext Bruxelles

Andere beurzen

17:37:04 14-06-2024
Variatie 5 dagen Verschilt.o.v.1jan(%)
137,8 EUR +1,40% UCB: Financiële kalender en winstcijfers | UCB | BE0003739530 | MarketScreener (2) +6,04% +74,71%
13/06 UCB kondigt nieuwe CIMZIA®-gegevens aan voor vrouwen die leven met chronische reumatische aandoeningen tijdens de zwangerschap, en voor mensen die leven met Ra en hoge reumafactorwaarden CI
13/06 Nieuwe studiedata ondersteunen waarde van Cimzia van UCB AM

Grafiek agenda UCB

9.YFGJq8nX9k_iFgMkIyYPhVnEIWSYQNJOIVrES5V9pAA.OiXOkqS7kC6mW1pub1FY8gbyWy_1FbkkeSP9COwik3EhYaTFgoSXCaV6aA~d20f8b4e3104e03ff2dd1216972c0188

Komende gebeurtenissen op UCB

19-06-2024 Citi European Healthcare Conference
20-06-2024 JP Morgan European Healthcare Conference
25-07-2024 07:00 Q2 2024 Cijferpublicaties
27-02-2025 07:00 Q4 2024 Cijferpublicaties
24-07-2025 Q2 2025 Cijferpublicaties (schatting)
19-02-2026 Q4 2025 Cijferpublicaties (schatting)
23-07-2026 Q2 2026 Cijferpublicaties (schatting)
25-02-2027 Q4 2026 Cijferpublicaties (schatting)

Gebeurtenissen op naam

12-06-2024 16:00 Capital Market Day
11-06-2024 Jefferies Fireside Chat Conference
06-06-2024 BNP Paribas Exane CEO Conference
03-06-2024 Barclays Hearing Out Healthcare Series - Fireside Chat
16-05-2024 Deutsche Bank R&D Call Series - Fireside Chat
26-04-2024 Détachement de slotdividend
25-04-2024 Algemene vergadering
17-04-2024 19:45 American Academy of Neurology Meeting - Poster No : P006
17-04-2024 19:45 American Academy of Neurology Meeting - Poster No : P005
17-04-2024 19:45 American Academy of Neurology Meeting - Poster No : P003
17-04-2024 16:00 American Academy of Neurology Meeting - Poster No : P003
17-04-2024 16:00 American Academy of Neurology Meeting - Poster No : P007
17-04-2024 16:00 American Academy of Neurology Meeting - Poster No : P002
17-04-2024 16:00 American Academy of Neurology Meeting - Poster No : P009
17-04-2024 01:30 American Academy of Neurology Meeting - Poster No : P008
17-04-2024 01:30 American Academy of Neurology Meeting - Poster No : P009
16-04-2024 19:45 American Academy of Neurology Meeting - Poster No : P009
15-04-2024 21:12 American Academy of Neurology Meeting - Oral
15-04-2024 19:45 American Academy of Neurology Meeting - Poster No : P011
15-04-2024 19:45 American Academy of Neurology Meeting - Poster No : P017

Dividenden van UCB in het verleden

26-04-2024 Jaarlijks dividend 0.952 EUR
28-04-2023 Jaarlijks dividend 0.931 EUR
29-04-2022 Jaarlijks dividend 0.91 EUR
30-04-2021 Jaarlijks dividend 0.889 EUR
04-05-2020 Jaarlijks dividend 0.868 EUR
26-04-2019 Jaarlijks dividend 0.847 EUR
27-04-2018 Jaarlijks dividend 0.826 EUR
28-04-2017 Jaarlijks dividend 0.805 EUR
29-04-2016 Jaarlijks dividend 0.803 EUR
04-05-2015 0.795 EUR

Geschiedenis van de jaarlijkse publicaties

Start boekjaardecember 2019 2020 2021 2022 2023 2024
Omzet
Miljoen EUR
Gepubliceerd
Verwachting
Spread
4 913
4 828
1.76%
5 347
5 193
2.97%
5 777
5 600
3.16%
5 517
5 362
2.89%
5 252
5 196
1.07%

5 642
EBITDA
Miljoen EUR
Gepubliceerd
Verwachting
Spread
1 431
1 386
3.25%
1 441
1 450
-0.59%
1 641
1 585
3.54%
1 260
1 180
6.82%
1 349
1 239
8.92%

1 360
Bedrijfsresultaat (EBIT)
Miljoen EUR
Gepubliceerd
Verwachting
Spread
1 118
1 121
-0.3%
1 093
1 119
-2.34%
1 318
1 250
5.45%
675
733
-7.96%
657
607
8.3%

690
Resultaat voor belastingen (EBT)
Miljoen EUR
Gepubliceerd
Verwachting
Spread
960
1 011
-5.04%
880
949
-7.32%
1 226
1 173
4.5%
511
604
-15.38%
441
445
-0.85%

505
Nettowinst (verlies)
Miljoen EUR
Gepubliceerd
Verwachting
Spread
792
797
-0.65%
732
753
-2.78%
1 058
986
7.29%
418
487
-14.1%
343
349
-1.82%

411
WPA
EUR
Gepubliceerd
Verwachting
Spread
4,23
4,20
0.69%
3,87
3,80
1.87%
5,60
5,34
4.94%
2,20
2,40
-8.42%
1,76
1,87
-5.77%

2,09
Datum van publicatie20/02/2025/02/2124/02/2222/02/2328/02/24-

Geschiedenis van de driemaandelijkse publicaties

Start boekjaardecember 2019 S2 2020 S1 2020 S2 2021 S1 2021 S2 2022 Q2 2022 S1 2022 S2 2023 S1 2023 S2 2024 S1 2024 S2
Omzet
Miljoen EUR
Gepubliceerd
Verwachting
Spread
2 590
2 501
3.55%
2 608
2 534
2.94%
2 739
2 616
4.72%
2 778
2 669
4.07%
2 999
2 848
5.31%

2 925
2 638
10.87%
2 592
2 520
2.84%
2 589
2 474
4.66%
2 663
2 526
5.42%

2 605

3 005
EBITDA
Miljoen EUR
Gepubliceerd
Verwachting
Spread
707
668
5.89%
783
770
1.69%
658
615
6.99%
843
790
6.71%
798
718
11.09%

814
735
10.82%
446
379
17.68%
801
599
33.65%
548


Bedrijfsresultaat (EBIT)
Miljoen EUR
Gepubliceerd
Verwachting
Spread
547
548
-0.23%
614
608
0.99%
479
531
-9.75%
682
673
1.4%
636
620
2.65%
234
264
-11.45%
551
548
0.61%
124
207
-40.06%
486
306
59.01%
171
39,6
331.82%

200

484
Resultaat voor belastingen (EBT)
Miljoen EUR
Gepubliceerd
Verwachting
Spread
416
508
-18.16%
458
517
-11.41%
422
516
-18.22%
643
565
13.91%
583
558
4.48%

481
470
2.34%
30,0
295
-89.83%
401
266
50.95%
40,0


Nettowinst (verlies)
Miljoen EUR
Gepubliceerd
Verwachting
Spread
381
410
-6.96%
363
441
-17.69%
369
369
0.09%
571
476
19.96%
487
420
16.04%

399
405
-1.48%
19,0
269
-92.94%
311
223
39.68%
32,0


WPA
EUR
Gepubliceerd
Verwachting
Spread
2,03
2,24
-9.24%
1,92
2,34
-17.95%
1,95
1,96
-0.68%
3,02
2,65
13.96%
2,58
2,44
5.74%

2,10
2,14
-1.87%
0,10
1,42
-92.96%
1,60
1,76
-9.09%



Datum van publicatie20/02/2027/07/2025/02/2129/07/2124/02/2228/07/2228/07/2222/02/2327/07/2328/02/24--

Komende gebeurtenissen in de UCB sector

11-07-2024 08:00 BONESUPPORT HOLDING AB: Q2 2024 Cijferpublicaties
16-07-2024 SWEDISH ORPHAN BIOVITRUM AB: Q2 2024 Cijferpublicaties
23-07-2024 BIOGEN INC.: Q2 2024 Cijferpublicaties (schatting)
23-07-2024 08:00 BIOGAIA AB: Q2 2024 Cijferpublicaties
24-07-2024 SAMSUNG BIOLOGICS CO.,LTD.: Q2 2024 Cijferpublicaties (schatting)
25-07-2024 PHARMA MAR, S.A.: Q2 2024 Cijferpublicaties (schatting)
25-07-2024 GRIFOLS, S.A.: Q2 2024 Cijferpublicaties (schatting)
25-07-2024 07:00 UCB: Q2 2024 Cijferpublicaties
26-07-2024 SK BIOSCIENCE CO.,LTD.: Q2 2024 Cijferpublicaties (schatting)
30-07-2024 BIOMARIN PHARMACEUTICAL INC.: Q2 2024 Cijferpublicaties (schatting)

Meer evenementen

Gebeurtenissen in het verleden in de sector UCB

23-05-2024 11:43 CONCORD BIOTECH LIMITED: Q4 2024 Cijferpublicaties
14-05-2024 17:35 GRIFOLS, S.A.: Q1 2024 Cijferpublicaties
14-05-2024 NATURECELL CO.,LTD.: Q1 2024 Cijferpublicaties
10-05-2024 PHARMARESEARCH CO., LTD.: Q1 2024 Cijferpublicaties
10-05-2024 MEDY-TOX INC.: Q1 2024 Cijferpublicaties
09-05-2024 22:05 AVIDITY BIOSCIENCES, INC.: Q1 2024 Cijferpublicaties
09-05-2024 22:05 ADMA BIOLOGICS, INC.: Q1 2024 Cijferpublicaties
09-05-2024 08:30 NXERA PHARMA CO., LTD.: Q1 2024 Cijferpublicaties
09-05-2024 HUGEL, INC.: Q1 2024 Cijferpublicaties
08-05-2024 22:16 CATALYST PHARMACEUTICALS, INC.: Q1 2024 Cijferpublicaties

Omzet - Kwartaal - Afwijkingspercentage

Kwartaalwinst - Afwijkingspercentage

Omzet - Jaarlijks - Afwijkingspercentage

Winst van het jaar - Afwijkingspercentage

  1. Beurs
  2. Aandelen
  3. Koers UCB
  4. Agenda UCB
Handhaaf en verhoog de prestaties van je beleggingen met ons team van experts aan jouw zijde Mijn beleggingen veiligstellen

UCB: Financiële kalender en winstcijfers | UCB | BE0003739530 | MarketScreener (3)

"); InvestingChannelQueue.push(function() { aICTags["oop"] = ic_page.defineOutOfPageTag("4Traders/quotepages","zppOOP"); aICTags["oop"].setKval({"adslot":"d_OOP_1"}); aICTags["oop"].render(); }); while (aAdsQueue.length) { (aAdsQueue.shift())(); } InvestingChannelQueue.push(function() { displayViewableAds('InvestingChannel'); $( window ).scroll(function() { displayViewableAds('InvestingChannel'); }); }); }gaEvent('adspv', 'InvestingChannel', 'US');googletag.cmd.push(function() { googletag.pubads().setTargeting('Edition', 'nl_BE');googletag.pubads().setTargeting('UserType', 'free');googletag.pubads().setTargeting('Content', 'equities');googletag.pubads().setTargeting('codezb', '5963');googletag.enableServices();googletag.pubads().collapseEmptyDivs();try{googletag.pubads().getSlots().forEach(function(slot){if(slot.getSlotElementId().startsWith('zpp')){;}else{googletag.pubads().refresh([slot],{changeCorrelator: false});}})}catch(error){console.error(error)}});$(document).ready(function() { $( document).on('zbv_visible',function () {startAdsService();}); if (document[zbv_hidden]===false) { startAdsService(); } });
UCB: Financiële kalender en winstcijfers | UCB | BE0003739530 | MarketScreener (2024)

FAQs

What is the guidance for UCB 2025? ›

2025 financial guidance –confirmed

Revenue in 2025 is expected to reach at least € 6 billion and the underlying profitability (adjusted EBITDA) should reach the low to mid-thirties in percent of revenue.

What is the credit rating of UCB Belgium? ›

Based on the latest update (January 2022), UCB rating is C+.

How many employees does UCB have? ›

Compare UCBJF With Other Stocks
UCB SA Annual Employee Count
20218,561
20208,371
20197,606
20187,495
10 more rows

What is the acceptance rate for the class of 2026 at UC Berkeley? ›

Historical acceptance rates for UC Berkeley are as follows: Class of 2026 UC Berkeley acceptance rate: 11% 2025 UC Berkeley acceptance rate: 15% 2024 UC Berkeley acceptance rate: 18%

What is the acceptance rate for UCB 2024? ›

For the class of 2024, UC Berkeley had an acceptance rate of around 16.8%. However, keep in mind that acceptance rates can fluctuate each year depending on various factors, such as the number of applicants and the overall applicant pool's strength.

What credit union is highest recommended? ›

Best credit unions
  • Best for no-fee checking: Alliant Credit Union.
  • Best for ATM access: PenFed Credit Union.
  • Best for high APY: Consumers Credit Union (CCU)
  • Best for low-interest credit cards: First Tech Federal Credit Union.
  • Best for military members: Navy Federal Credit Union.
Jun 1, 2024

Is B3 a good credit rating? ›

Moody's assigns its B3 rating for “obligations considered speculative and subject to high credit risk.”1 Entities that receive this rating may be experiencing financial instability or hold inadequate cash reserves relative to their business needs, debt or other financial obligations.

What is the strongest credit quality? ›

Highest credit quality

'AAA' ratings denote the lowest expectation of default risk.

Does UCB pay well? ›

At UCB, the highest paid job is a Director of Sales at $222,052 annually and the lowest is a CS Rep at $46,887 annually. Average UCB salaries by department include: Finance at $103,551, Customer Support at $64,309, Admin at $60,380, and Legal at $184,467. Half of UCB salaries are above $122,649.

What is the UCB Pharma controversy? ›

The government alleged that UCB promoted the sale of Keppra for off-label use in the treatment of migraine by generating and disseminating posters representing that Keppra was safe and effective for treating migraine based on purportedly independent investigator-initiated studies.

Who is the owner of UCB Bank? ›

The government owns shares in the bank. The bank was listed in the Dhaka Stock Exchange (DSE) by 1986 and Chittagong Stock Exchange (CSE) by 1995.

What is the acceptance rate for UC 2025? ›

Class of 2025 acceptance rate: 29% Class of 2024 acceptance rate: 30%

Is a 3.7 good for Berkeley? ›

Is your high school GPA good enough for UC Berkeley? The average high school GPA for admitted students at UC Berkeley is 3.89 on a 4.0 scale. (You can calculate your high school a GPA here.)

Does UCB require letters of recommendation? ›

A: We will request letters from students we feel additional information could be useful in our review process. Only a small percent of applicants will be selected to submit letters, and they can choose to submit letters or not. Not doing so will not negatively impact the review.

What is the acceptance rate for University of California Berkeley UCB graduate? ›

University of California Berkeley Admission Highlights 2024
ParticularsRequirements
Application FeeUG application fee: USD 80 PG application fee: USD 155
Acceptance Rate9 % ( International applicants)
English Language Tests AcceptedTOEFL / IELTS/ Duolingo
3 more rows
May 9, 2024

Top Articles
Latest Posts
Article information

Author: Otha Schamberger

Last Updated:

Views: 6501

Rating: 4.4 / 5 (75 voted)

Reviews: 90% of readers found this page helpful

Author information

Name: Otha Schamberger

Birthday: 1999-08-15

Address: Suite 490 606 Hammes Ferry, Carterhaven, IL 62290

Phone: +8557035444877

Job: Forward IT Agent

Hobby: Fishing, Flying, Jewelry making, Digital arts, Sand art, Parkour, tabletop games

Introduction: My name is Otha Schamberger, I am a vast, good, healthy, cheerful, energetic, gorgeous, magnificent person who loves writing and wants to share my knowledge and understanding with you.